(Q37679127)

21 August 2017

1 reference

title

Atrial fibrillation and bisphosphonate therapy (English)

1 reference

21 August 2017

0 references

Michael Pazianas

1 reference

21 August 2017

Juliet Compston

series ordinal

1 reference

21 August 2017

Christopher L-H Huang

series ordinal

1 reference

21 August 2017

publication date

1 January 2010

1 reference

Journal of Bone and Mineral Research

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

2-10

1 reference

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Statins and polyunsaturated fatty acids for treatment of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Status of the epidemiology of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Alendronate and atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Zoledronic acid and clinical fractures and mortality after hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Atrial fibrillation in fracture patients treated with oral bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Use of alendronate and risk of incident atrial fibrillation in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Bisphosphonates and atrial fibrillation: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Relationship between osteoporosis and cardiovascular disease in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Structural remodeling in atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Crosstalk between L-type calcium channels and ZnT-1, a new player in rate-dependent cardiac electrical remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Calcium-mediated triggered activity is an underlying cellular mechanism of ectopy originating from the pulmonary vein in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Pharmacological changes in cellular Ca2+ homeostasis parallel initiation of atrial arrhythmogenesis in murine Langendorff-perfused hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Molecular basis of electrical remodeling in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Gap junction alterations in human cardiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Cardiac connexins as candidate genes for idiopathic atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Effects of Clodronate and Pamidronate on Splenic and Hepatic Phagocytic Cells of Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Alendronate affects calcium dynamics in cardiomyocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

A novel non-containing-nitrogen bisphosphonate inhibits both in vitro and in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

MMP inhibition and downregulation by bisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

A multicenter risk index for atrial fibrillation after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Inflammation as a risk factor for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Is atrial fibrillation an inflammatory disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Macrophage depletion in hypertensive rats accelerates development of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.091201

21 January 2018

Identifiers

DOI

10.1359/JBMR.091201

1 reference

21 August 2017

1 reference